Canaccord Genuity Maintains Hold on Amgen, Raises Price Target to $440
Benzinga Newsdesk 1 day ago
Analyst RatingsNewsPrice TargetHot
Canaccord Genuity analyst Gary Nachman maintains Amgen (NASDAQ:AMGN) with a Hold and raises the price target from $384 to $440.
Canaccord Genuity analyst Gary Nachman maintains Amgen (NASDAQ:AMGN) with a Hold and raises the price target from $384 to $440.